Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Latest Articles
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • Archive
  • Front Matter
  • News
    • For the Press
    • Highlights from Latest Articles
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Purpose and Scope
    • Editorial and Journal Policies
    • Submission Procedures
    • For Reviewers
    • Author FAQ
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Latest Articles
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • Archive
  • Front Matter
  • News
    • For the Press
    • Highlights from Latest Articles
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Purpose and Scope
    • Editorial and Journal Policies
    • Submission Procedures
    • For Reviewers
    • Author FAQ

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron

Peter W. Faber, Janet R. Alter, Marcy E. MacDonald, and Anne C. Hart
PNAS January 5, 1999 96 (1) 179-184; https://doi.org/10.1073/pnas.96.1.179
Peter W. Faber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet R. Alter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcy E. MacDonald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne C. Hart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  1. Edited by H. Robert Horvitz, Massachusetts Institute of Technology, Cambridge, MA, and approved November 6, 1998 (received for review August 21, 1998)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Online Impact

 

Article Information

vol. 96 no. 1 179-184
DOI: 
https://doi.org/10.1073/pnas.96.1.179
PubMed: 
9874792

Published By: 
National Academy of Sciences
Print ISSN: 
0027-8424
Online ISSN: 
1091-6490
History: 
  • Received August 21, 1998
  • Published January 5, 1999.

Copyright & Usage: 
Copyright © 1999, The National Academy of Sciences

Author Information

  1. Peter W. Faber*†‡,
  2. Janet R. Alter*†‡,
  3. Marcy E. MacDonald§, and
  4. Anne C. Hart*†¶
  1. *Cancer Center and §Molecular Neurogenetics Unit, Massachusetts General Hospital East, and †Department of Pathology, Harvard Medical School, Charlestown, MA 02129
  1. Edited by H. Robert Horvitz, Massachusetts Institute of Technology, Cambridge, MA, and approved November 6, 1998 (received for review August 21, 1998)

Footnotes

    • ↵‡ P.W.F. and J.R.A. contributed equally to this work.

    • ↵¶ To whom reprint requests should be addressed at: Cancer Center, Massachusetts General Hospital East, Building 149-7202, Charlestown, MA 02129. e-mail: hart{at}helix.mgh.harvard.edu.

    • This paper was submitted directly (Track II) to the Proceedings Office.

    Cited By...

    • 217 Citations
    • 185 Citations
    • Google Scholar

    This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

    • Glutamine Repeats and Neurodegeneration
      Huda Y. Zoghbi, Harry T. Orr
      Annual Review of Neuroscience 2000 23 1
    • Cellular Defenses against Unfolded Proteins
      Michael Y. Sherman, Alfred L. Goldberg
      Neuron 2001 29 1
    • Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
      Ludger Schöls, Peter Bauer, Thorsten Schmidt, Thorsten Schulte, Olaf Riess
      The Lancet Neurology 2004 3 5
    • Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology
      Maxwell C. K. Leung, Phillip L. Williams, Alexandre Benedetto, Catherine Au, Kirsten J. Helmcke, Michael Aschner, Joel N. Meyer
      Toxicological Sciences 2008 106 1
    • Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
      Chiara Zuccato, Marta Valenza, Elena Cattaneo
      Physiological Reviews 2010 90 3
    • Finding function in novel targets: C. elegans as a model organism
      Titus Kaletta, Michael O. Hengartner
      Nature Reviews Drug Discovery 2006 5 5
    • The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans
      J. F. Morley, H. R. Brignull, J. J. Weyers, R. I. Morimoto
      Proceedings of the National Academy of Sciences 2002 99 16
    • Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery
      Udai Bhan Pandey, Charles D. Nichols, Eric L. Barker
      Pharmacological Reviews 2011 63 2
    • Heat shock genes — integrating cell survival and death
      Richa Arya, Moushami Mallik, Subhash C Lakhotia
      Journal of Biosciences 2007 32 3
    • Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
      S. H. Satyal, E. Schmidt, K. Kitagawa, N. Sondheimer, S. Lindquist, J. M. Kramer, R. I. Morimoto
      Proceedings of the National Academy of Sciences 2000 97 11
    • Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
      Hyunkyung Jeong, Florian Then, Thomas J. Melia, Joseph R. Mazzulli, Libin Cui, Jeffrey N. Savas, Cindy Voisine, Paolo Paganetti, Naoko Tanese, Anne C. Hart, Ai Yamamoto, Dimitri Krainc
      Cell 2009 137 1
    • Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease
      James F. Gusella, Marcy E. MacDonald
      Nature Reviews Neuroscience 2000 1 2
    • Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?
      Matthew S. Goldberg, Peter T. Lansbury Jr
      Nature Cell Biology 2000 2 7
    • Choosing an animal model for the study of Huntington's disease
      Mahmoud A. Pouladi, A. Jennifer Morton, Michael R. Hayden
      Nature Reviews Neuroscience 2013 14 10
    • Golgi Fragmentation Occurs in the Cells with Prefibrillar α-Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion
      Nirmal Gosavi, He-Jin Lee, Jun Sung Lee, Smita Patel, Seung-Jae Lee
      Journal of Biological Chemistry 2002 277 50
    • Pathogenesis of polyglutamine disorders: aggregation revisited
      A. Michalik, C. Van Broeckhoven
      Human Molecular Genetics 2003 12 suppl 2
    • Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans
      Katherine A. Steinkraus, Erica D. Smith, Christina Davis, Daniel Carr, William R. Pendergrass, George L. Sutphin, Brian K. Kennedy, Matt Kaeberlein
      Aging Cell 2008 7 3
    • Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay
      V. Heiser, S. Engemann, W. Brocker, I. Dunkel, A. Boeddrich, S. Waelter, E. Nordhoff, R. Lurz, N. Schugardt, S. Rautenberg, C. Herhaus, G. Barnickel, H. Bottcher, H. Lehrach, E. E. Wanker
      Proceedings of the National Academy of Sciences 2002 99 Supplement 4
    • Recent advances in understanding the pathogenesis of Huntington's disease
      P.Hemachandra Reddy, Maya Williams, Danilo A Tagle
      Trends in Neurosciences 1999 22 6
    • Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death
      J. A. Parker, J. B. Connolly, C. Wellington, M. Hayden, J. Dausset, C. Neri
      Proceedings of the National Academy of Sciences 2001 98 23
    • The biochemistry of neuronal necrosis: rogue biology?
      Popi Syntichaki, Nektarios Tavernarakis
      Nature Reviews Neuroscience 2003 4 8
    • Neurotoxic effects of TDP-43 overexpression in C. elegans
      Peter E.A. Ash, Yong-Jie Zhang, Christine M. Roberts, Tassa Saldi, Harald Hutter, Emanuele Buratti, Leonard Petrucelli, Christopher D. Link
      Human Molecular Genetics 2010 19 16
    • Apoptosis in Huntington's disease
      Miriam A. Hickey, Marie-Françoise Chesselet
      Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003 27 2
    • Dying for a cause: invertebrate genetics takes on human neurodegeneration
      Monica Driscoll, Beate Gerstbrein
      Nature Reviews Genetics 2003 4 3
    • Chaperone networks: Tipping the balance in protein folding diseases
      Cindy Voisine, Jesper Søndergaard Pedersen, Richard I. Morimoto
      Neurobiology of Disease 2010 40 1
    • HUMAN NEURODEGENERATIVE DISEASE MODELING USING DROSOPHILA
      Nancy M. Bonini, Mark E. Fortini
      Annual Review of Neuroscience 2003 26 1
    • Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z
      Sager J. Gosai, Joon Hyeok Kwak, Cliff J. Luke, Olivia S. Long, Dale E. King, Kevin J. Kovatch, Paul A. Johnston, Tong Ying Shun, John S. Lazo, David H. Perlmutter, Gary A. Silverman, Stephen C. Pak, Anne C. Hart
      PLoS ONE 2010 5 11
    • Mitochondrial structural and functional dynamics in Huntington's disease
      P. Hemachandra Reddy, Peizhong Mao, Maria Manczak
      Brain Research Reviews 2009 61 1
    • Altered transcription in yeast expressing expanded polyglutamine
      R. E. Hughes, R. S. Lo, C. Davis, A. D. Strand, C. L. Neal, J. M. Olson, S. Fields
      Proceedings of the National Academy of Sciences 2001 98 23
    • Protein Metabolism and Homeostasis in Aging
      Elise A. Kikis, Tali Gidalevitz, Richard I. Morimoto
      2010 694
    • Alternatives to animal testing: A review
      Sonali K. Doke, Shashikant C. Dhawale
      Saudi Pharmaceutical Journal 2015 23 3
    • Caenorhabditis elegans: A versatile platform for drug discovery
      Marta Artal-Sanz, Liesbeth de Jong, Nektarios Tavernarakis
      Biotechnology Journal 2006 1 12
    • Modulation of Prion-dependent Polyglutamine Aggregation and Toxicity by Chaperone Proteins in the Yeast Model
      Kavita C. Gokhale, Gary P. Newnam, Michael Y. Sherman, Yury O. Chernoff
      Journal of Biological Chemistry 2005 280 24
    • The molecular genetics of Huntington disease — a history
      Gillian P. Bates
      Nature Reviews Genetics 2005 6 10
    • A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in α-synuclein transgenic C . elegans
      Tomoki Kuwahara, Akihiko Koyama, Shingo Koyama, Sawako Yoshina, Chang-Hong Ren, Takeo Kato, Shohei Mitani, Takeshi Iwatsubo
      Human Molecular Genetics 2008 17 19
    • Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
      Cindy Voisine, Hemant Varma, Nicola Walker, Emily A. Bates, Brent R. Stockwell, Anne C. Hart, Xiao-Jiang Li
      PLoS ONE 2007 2 6
    • Trehalose extends longevity in the nematode Caenorhabditis elegans
      Yoko Honda, Masashi Tanaka, Shuji Honda
      Aging Cell 2010 9 4
    • Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity
      P. W. Faber, C. Voisine, D. C. King, E. A. Bates, A. C. Hart
      Proceedings of the National Academy of Sciences 2002 99 26
    • The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis
      S. Holbert, I. Denghien, T. Kiechle, A. Rosenblatt, C. Wellington, M. R. Hayden, R. L. Margolis, C. A. Ross, J. Dausset, R. J. Ferrante, C. Neri
      Proceedings of the National Academy of Sciences 2001 98 4
    • A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network
      M. Catarina Silva, Susan Fox, Monica Beam, Happy Thakkar, Margarida D. Amaral, Richard I. Morimoto, Tricia R. Serio
      PLoS Genetics 2011 7 12
    • Modeling human neurodegenerative diseases in transgenic systems
      Miguel A. Gama Sosa, Rita De Gasperi, Gregory A. Elder
      Human Genetics 2012 131 4
    • Polyglutamine pathogenesis
      M. F. Perutz, P. S. Harper, M. A. Ferguson-Smith, Christopher A. Ross, Jonathan D. Wood, Gabriele Schilling, Matthew F. Peters, Frederick C. Nucifora, Jillian K. Cooper, Alan H. Sharp, Russell L. Margolis, David R. Borchelt
      Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 1999 354 1386
    • Transgenic invertebrate models of age-associated neurodegenerative diseases
      Christopher D Link
      Mechanisms of Ageing and Development 2001 122 14
    • Aggregates in neurodegenerative disease: crowds and power?
      Phuong B Tran, Richard J Miller
      Trends in Neurosciences 1999 22 5
    • Huntingtin in health and disease
      Anne B. Young
      Journal of Clinical Investigation 2003 111 3
    • Huntingtin in health and disease
      Anne B. Young
      Journal of Clinical Investigation 2003 111 3
    • O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases
      P. Wang, B. D. Lazarus, M. E. Forsythe, D. C. Love, M. W. Krause, J. A. Hanover
      Proceedings of the National Academy of Sciences 2012 109 43
    • Amyloid, Prions, and Other Protein Aggregates, Part B
      Heather R. Brignull, James F. Morley, Susana M. Garcia, Richard I. Morimoto
      2006 412
    • Neurotoxic protein oligomerisation associated with polyglutamine diseases
      Sarah L. Hands, Andreas Wyttenbach
      Acta Neuropathologica 2010 120 4
    • The role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogaster
      Ozlem Altintas, Sangsoon Park, Seung-Jae V. Lee
      BMB Reports 2016 49 2
    • Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation
      Kunitoshi Yamanaka, Yoshiko Okubo, Toshinobu Suzaki, Teru Ogura
      Journal of Structural Biology 2004 146 1-2
    • Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans
      Maria Dimitriadi, Anne C. Hart
      Neurobiology of Disease 2010 40 1
    • Conversion of Green Fluorescent Protein into a Toxic, Aggregation-prone Protein by C-terminal Addition of a Short Peptide
      Christopher D. Link, Virginia Fonte, Brian Hiester, John Yerg, Jmil Ferguson, Susan Csontos, Michael A. Silverman, Gretchen H. Stein
      Journal of Biological Chemistry 2006 281 3
    • Molecular Biology of Neurodegenerative Diseases
      Zhiqiang Zheng, Marc I. Diamond
      2012 107
    • Mice transgenic for the human Huntington’s disease mutation have reduced sensitivity to kainic acid toxicity
      A.J Morton, W Leavens
      Brain Research Bulletin 2000 52 1
    • Modeling Molecular and Cellular Aspects of Human Disease Using the Nematode Caenorhabditis elegans
      Gary A Silverman, Cliff J Luke, Sangeeta R Bhatia, Olivia S Long, Anne C Vetica, David H Perlmutter, Stephen C Pak
      Pediatric Research 2009 65 1
    • Modeling neurodegenerative diseases in Caenorhabditis elegans
      Jia Li, Weidong Le
      Experimental Neurology 2013 250
    • Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans : rescue by the DAF-16 and HSF-1 pathways
      Andreia Teixeira-Castro, Michael Ailion, Ana Jalles, Heather R. Brignull, João L. Vilaça, Nuno Dias, Pedro Rodrigues, João F. Oliveira, Andreia Neves-Carvalho, Richard I. Morimoto, Patrícia Maciel
      Human Molecular Genetics 2011 20 15
    • Cdc42-interacting protein 4 binds to huntingtin: Neuropathologic and biological evidence for a role in Huntington's disease
      S. Holbert, A. Dedeoglu, S. Humbert, F. Saudou, R. J. Ferrante, C. Neri
      Proceedings of the National Academy of Sciences 2003 100 5
    • Toward an Understanding of Polyglutamine Neurodegeneration
      Henry L. Paulson
      Brain Pathology 2000 10 2
    • Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks
      Heather R. Brignull, James F. Morley, Richard I. Morimoto
      2007 594
    • Kinetically Competing Huntingtin Aggregation Pathways Control Amyloid Polymorphism and Properties
      Murali Jayaraman, Rakesh Mishra, Ravindra Kodali, Ashwani K. Thakur, Leonardus M. I. Koharudin, Angela M. Gronenborn, Ronald Wetzel
      Biochemistry 2012 51 13
    • Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans
      Li-Chun Wang, Kuan-Yu Chen, Huichin Pan, Chia-Chieh Wu, Po-Hsuan Chen, Yuan-Ting Liao, Chin Li, Min-Lang Huang, Kuang-Ming Hsiao
      Cellular and Molecular Life Sciences 2011 68 7
    • Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation inDrosophila
      Doris Kretzschmar, Jakob Tschäpe, Alexandre Bettencourt Da Cruz, Esther Asan, Burkhard Poeck, Roland Strauss, Gert O. Pflugfelder
      Glia 2005 49 1
    • Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation
      Liliana Malinovska, Sandra Palm, Kimberley Gibson, Jean-Marc Verbavatz, Simon Alberti
      Proceedings of the National Academy of Sciences 2015 112 20
    • Disrupted-in-Schizophrenia 1-mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signaling
      S.-Y. Chen, P.-H. Huang, H.-J. Cheng
      Proceedings of the National Academy of Sciences 2011 108 14
    • Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis
      Tzu-Kang Sang, Chenjian Li, Wencheng Liu, Antony Rodriguez, John M. Abrams, S. Lawrence Zipursky, George R. Jackson
      Human Molecular Genetics 2005 14 3
    • Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans
      Roongpetch Keowkase, Marwa Aboukhatwa, Yuan Luo
      Neuropharmacology 2010 59 4-5
    • Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model
      Sudip Mondal, Evan Hegarty, Chris Martin, Sertan Kutal Gökçe, Navid Ghorashian, Adela Ben-Yakar
      Nature Communications 2016 7 1
    • Small molecule drug discovery for Huntington's Disease
      Wolfgang Fecke, Marco Gianfriddo, Giovanni Gaviraghi, Georg C. Terstappen, Freddy Heitz
      Drug Discovery Today 2009 14 9-10
    • A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation
      Thomas R. Peskett, Frédérique Rau, Jonathan O’Driscoll, Rickie Patani, Alan R. Lowe, Helen R. Saibil
      Molecular Cell 2018 70 4
    • Medical significance ofCaenorhabditis elegans
      A Aziz Aboobaker, Mark L Blaxter
      Annals of Medicine 2000 32 1
    • Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
      Patricia M. Chege, Gawain McColl
      Frontiers in Aging Neuroscience 2014 6
    • Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell model
      Wenfei Wang, Wenzhen Duan, Shuichi Igarashi, Hokuto Morita, Masayuki Nakamura, Christopher A. Ross
      Neurobiology of Disease 2005 20 2
    • Huntington's disease
      Christopher A Ross, Russell L Margolis
      Clinical Neuroscience Research 2001 1 1-2
    • Antioxidant and neuroprotective effects of Dictyophora indusiata polysaccharide in Caenorhabditis elegans
      Ju Zhang, Ruona Shi, Haifeng Li, Yanxia Xiang, Lingyun Xiao, Minghua Hu, Fangli Ma, Chung Wah Ma, Zebo Huang
      Journal of Ethnopharmacology 2016 192
    • Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases
      Olga Sin, Helen Michels, Ellen A.A. Nollen
      Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014 1842 10
    • Studying Human Neurodegenerative Diseases in Flies and Worms
      Mel B. Feany
      Journal of Neuropathology & Experimental Neurology 2000 59 10
    • The early cellular pathology of Huntington’s disease
      Xiao-Jiang Li
      Molecular Neurobiology 1999 20 2-3
    • Yeast, Flies, Worms, and Fish in the Study of Human Disease
      Iswar K. Hariharan, Daniel A. Haber
      New England Journal of Medicine 2003 348 24
    • Transgenic animal models of neurodegeneration based on human genetic studies
      Brandon K. Harvey, Christopher T. Richie, Barry J. Hoffer, Mikko Airavaara
      Journal of Neural Transmission 2011 118 1
    • Animal models of neurodegenerative diseases
      Fabiola Mara Ribeiro, Elizabeth Ribeiro da Silva Camargos, Leonardo Cruz de Souza, Antonio Lucio Teixeira
      Revista Brasileira de Psiquiatria 2013 35 suppl 2
    • A protocol describing pharynx counts and a review of other assays of apoptotic cell death in the nematode worm Caenorhabditis elegans
      Hillel T Schwartz
      Nature Protocols 2007 2 3
    • Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies
      Lin-hui WANG, Zheng-hong QIN
      Acta Pharmacologica Sinica 2006 27 10
    • Initial process of polyglutamine aggregate formation in vivo
      Yoko Kimura, Sumiko Koitabashi, Akira Kakizuka, Takashi Fujita
      Genes to Cells 2001 6 10
    • Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity
      Zhong-Qin Liang, Xiao-Xia Wang, Yumei Wang, De-Maw Chuang, Marian DiFiglia, Thomas N. Chase, Zheng-Hong Qin
      Neurobiology of Disease 2005 20 2
    • Tissue Transglutaminase Selectively Modifies Proteins Associated with Truncated Mutant Huntingtin in Intact Cells
      Wanjoo Chun, Mathieu Lesort, Janusz Tucholski, Peter W. Faber, Marcy E. MacDonald, Christopher A. Ross, Gail V.W. Johnson
      Neurobiology of Disease 2001 8 3
    • Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease
      Mahesh Kandasamy, Ralf Reilmann, Jürgen Winkler, Ulrich Bogdahn, Ludwig Aigner
      Neurology Research International 2011 2011
    • Endoplasmic reticulum stress: The cause and solution to Huntington's disease?
      Yuwei Jiang, Sarah R. Chadwick, Patrick Lajoie
      Brain Research 2016 1648
    • Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia
      Lesley Jones, Alis Hughes
      2011 98
    • The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington’s disease model
      Matthew B. Veldman, Yesenia Rios-Galdamez, Xiao-Hong Lu, Xiaofeng Gu, Wei Qin, Song Li, X. William Yang, Shuo Lin
      Molecular Neurodegeneration 2015 10 1
    • Using C. elegans to Decipher the Cellular and Molecular Mechanisms Underlying Neurodevelopmental Disorders
      Carlos Bessa, Patrícia Maciel, Ana João Rodrigues
      Molecular Neurobiology 2013 48 3
    • A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans
      B A Martinez, H Kim, A Ray, G A Caldwell, K A Caldwell
      Cell Death & Disease 2015 6 10
    • Inhibition of Protein Misfolding/Aggregation Using Polyglutamine Binding Peptide QBP1 as a Therapy for the Polyglutamine Diseases
      H. Akiko Popiel, Toshihide Takeuchi, James R. Burke, Warren J. Strittmatter, Tatsushi Toda, Keiji Wada, Yoshitaka Nagai
      Neurotherapeutics 2013 10 3
    • Jason M. Kinchen, Michael O. Hengartner
      2004 65
    • Coenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration
      L. R. Earls, M. L. Hacker, J. D. Watson, D. M. Miller
      Proceedings of the National Academy of Sciences 2010 107 32
    • No post-genetics era in human disease research
      James Gusella, Marcy MacDonald
      Nature Reviews Genetics 2002 3 1
    • Oxidative stress is increased in C. elegans models of Huntington’s disease but does not contribute to polyglutamine toxicity phenotypes
      Emily Machiela, Dylan J. Dues, Megan M. Senchuk, Jeremy M. Van Raamsdonk
      Neurobiology of Disease 2016 96
    • Presynaptic dysfunction in Huntington's disease
      José L. Rozas, Leonardo Gómez-Sánchez, Cristina Tomás-Zapico, José J. Lucas, Rafael Fernández-Chacón
      Biochemical Society Transactions 2010 38 2
    • Role of the ubiquitin–proteasome system in nervous system function and disease: using C. elegans as a dissecting tool
      Márcio S. Baptista, Carlos B. Duarte, Patrícia Maciel
      Cellular and Molecular Life Sciences 2012 69 16
    • Neural Cell Transplantation
      Wendy Phillips, Andrew Michell, Harald Pruess, Roger A. Barker
      2009 549
    • The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases
      H. Akiko Popiel, James R. Burke, Warren J. Strittmatter, Shinya Oishi, Nobutaka Fujii, Toshihide Takeuchi, Tatsushi Toda, Keiji Wada, Yoshitaka Nagai
      Journal of Amino Acids 2011 2011
    • Non-apoptotic cell death in Caenorhabditis elegans
      Manolis Vlachos, Nektarios Tavernarakis
      Developmental Dynamics 2010 239 5
    • C. elegans Expressing Human β2-Microglobulin: A Novel Model for Studying the Relationship between the Molecular Assembly and the Toxic Phenotype
      Luisa Diomede, Cristina Soria, Margherita Romeo, Sofia Giorgetti, Loredana Marchese, Patrizia Palma Mangione, Riccardo Porcari, Irene Zorzoli, Mario Salmona, Vittorio Bellotti, Monica Stoppini, Efthimios M. C. Skoulakis
      PLoS ONE 2012 7 12
    • Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases
      Liang Ma, Yudan Zhao, Yuchen Chen, Biao Cheng, Anlin Peng, Kun Huang
      European Journal of Pharmacology 2018 819
    • Hyperkinetic Movement Disorders
      Karen N. Mcfarland, Jang-Ho J. Cha
      2011 100
    • Inclusion Body Myositis: A View from the Caenorhabditis elegans Muscle
      Daniela L. Rebolledo, Alicia N. Minniti, Paula M. Grez, Ricardo Fadic, Rebecca Kohn, Nibaldo C. Inestrosa
      Molecular Neurobiology 2008 38 2
    • Non-developmentally programmed cell death in Caenorhabditis elegans
      Nikos Kourtis, Nektarios Tavernarakis
      Seminars in Cancer Biology 2007 17 2
    • Overexpression of dystrobrevin delays locomotion defects and muscle degeneration in a dystrophin-deficient Caenorhabditis elegans
      Kathrin Gieseler, Karine Grisoni, Marie-Christine Mariol, Laurent Ségalat
      Neuromuscular Disorders 2002 12 4
    • Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
      Toshihide Takeuchi, Yoshitaka Nagai
      Brain Sciences 2017 7 12
    • Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegeneration
      B Nelson, S Nishimura, H Kanuka, E Kuranaga, M Inoue, G Hori, H Nakahara, M Miura
      Cell Death & Differentiation 2005 12 8
    • Mechanisms of aging-related proteinopathies in Caenorhabditis elegans
      Dong-Kyu Kim, Tae Ho Kim, Seung-Jae Lee
      Experimental & Molecular Medicine 2016 48 10
    • O-GlcNAc cycling shows neuroprotective potential inC. elegansmodels of neurodegenerative disease
      John A Hanover, Peng Wang
      Worm 2013 2 4
    • Pharmacological intervention in invertebrate aging
      Gordon J. Lithgow, Matthew S. Gill, Anders Olsen, James N. Sampayo
      AGE 2005 27 3
    • C. elegans screening strategies to identify pro-longevity interventions
      Silvia Maglioni, Nayna Arsalan, Natascia Ventura
      Mechanisms of Ageing and Development 2016 157
    • Morphological remodeling of C. elegans neurons during aging is modified by compromised protein homeostasis
      Elena M Vayndorf, Courtney Scerbak, Skyler Hunter, Jason R Neuswanger, Marton Toth, J Alex Parker, Christian Neri, Monica Driscoll, Barbara E Taylor
      npj Aging and Mechanisms of Disease 2016 2 1
    • Huntington’s disease: A decade beyond gene discovery
      Penelope Hogarth
      Current Neurology and Neuroscience Reports 2003 3 4
    • New Approaches to the Pathology and Genetics of Neurodegeneration
      Mel B. Feany
      The American Journal of Pathology 2010 176 5
    • Pluripotent Stem Cells Models for Huntington's Disease: Prospects and Challenges
      Richard L. Carter, Anthony W.S. Chan
      Journal of Genetics and Genomics 2012 39 6
    • Kinga Michno, Diana van de Hoef, Hong Wu, Gabrielle L. Boulianne
      2005 71
    • Preclinical models: Needed in translation? A Pro/Con debate
      Thomas Philips, Jeffrey D. Rothstein, Mahmoud A. Pouladi
      Movement Disorders 2014 29 11
    • A liquid phase based C. elegans behavioral analysis system identifies motor activity loss in a nematode Parkinson's disease model
      Maohua Zheng, Olga Gorelenkova, Jiong Yang, Zhaoyang Feng
      Journal of Neuroscience Methods 2012 204 2
    • Insulin signaling in the aging of healthy and proteotoxically stressed mechanosensory neurons
      Courtney Scerbak, Elena M. Vayndorf, J. Alex Parker, Christian Neri, Monica Driscoll, Barbara E. Taylor
      Frontiers in Genetics 2014 5
    • The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease
      Elise A. Kikis
      Biology Direct 2016 11 1
    • Circumvention of Chaperone Requirement for Aggregate Formation of a Short Polyglutamine Tract by the Co-expression of a Long Polyglutamine Tract
      Yoko Kimura, Sumiko Koitabashi, Akira Kakizuka, Takashi Fujita
      Journal of Biological Chemistry 2002 277 40
    • In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C. elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects
      Altar Sorkaç, Ivan C. Alcantara, Anne C. Hart, Denis Dupuy
      PLOS ONE 2016 11 12
    • The Pharmacology of Neurogenesis and Neuroenhancement
      Brian Kraemer, Gerard D. Schellenberg*
      2007 77
    • A C. elegans Homolog of Huntingtin-Associated Protein 1 is Expressed in Chemosensory Neurons and in a Number of Other Somatic Cell Types
      Kristina B. Mercer, Sarah M. Szlam, Erin Manning, Kim M. Gernert, Walter W. Walthall, Guy M. Benian, Claire-Anne Gutekunst
      Journal of Molecular Neuroscience 2009 37 1
    • C. elegans comme modèle pour les maladies dégénératives héréditaires humaines
      Christian Néri, Laurent Ségalat
      médecine/sciences 2003 19 12
    • High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics
      Adela Ben-Yakar
      ASSAY and Drug Development Technologies 2019 17 1
    • Spinal Muscular Atrophy
      P. O’Hern, E.L. Garcia, L.T. Hao, A.C. Hart, A.G. Matera, C.E. Beattie
      2017
    • A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles
      Amy L. Lee, Hailey M. Ung, L. Paul Sands, Elise A. Kikis, Patrick van der Wel
      PLOS ONE 2017 12 3
    • Alpha-Synuclein
      Mandy Koopman, Renée I. Seinstra, Ellen A. A. Nollen
      2019 1948
    • Approaches for Studying Autophagy in Caenorhabditis elegans
      Yanfang Chen, Vincent Scarcelli, Renaud Legouis
      Cells 2017 6 3
    • Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity
      Michelle D. Leach, TaeHyung Kim, Sonja E. DiGregorio, Cathy Collins, Zhaolei Zhang, Martin L. Duennwald, Leah E. Cowen
      G3: Genes|Genomes|Genetics 2017 7 1
    • Invertebrate models of neurologic disease: Insights into pathogenesis and therapy
      Leslie Michels Thompson, J. Lawrence Marsh
      Current Neurology and Neuroscience Reports 2003 3 5
    • Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington’s Disease
      Minhee Jang, Seung Eun Lee, Ik-Hyun Cho
      Frontiers in Cellular Neuroscience 2018 12
    • Ageing: Lessons from C. elegans
      Seon Woo A. An, Murat Artan, Sangsoon Park, Ozlem Altintas, Seung-Jae V. Lee
      2017
    • Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model
      So-Hyun Lee, Tai-Seung Nam, Kun-Hee Kim, Jin Hee Kim, Woong Yoon, Suk-Hee Heo, Min Jung Kim, Boo Ahn Shin, Ming-Der Perng, Hyon E. Choy, Jihoon Jo, Myeong-Kyu Kim, Seok-Yong Choi
      BMC Neurology 2017 17 1
    • Animal models of amyotrophic lateral sclerosis and Huntington’s disease
      Abu M. T. Islam, Jina Kwak, Yoo Jung Jung, Yun Kee
      Genes & Genomics 2014 36 4
    • Clinical and Research Advances in Huntington's Disease
      M. SuttonBrown, O. Suchowersky
      Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2003 30 S1
    • Disease Gene Identification
      Javier Apfeld, Scott Alper
      2018 1706
    • Experimental Models for Identifying Modifiers of Polyglutamine-Induced Aggregation and Neurodegeneration
      Barbara Calamini, Donald C. Lo, Linda S. Kaltenbach
      Neurotherapeutics 2013 10 3
    • Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences
      Claudia Rangel-Barajas, George V. Rebec
      Current Protocols in Neuroscience 2018 83 1
    • Targeted nucleotide exchange in the CAG repeat region of the human HD gene
      Hetal Parekh-Olmedo, Eric B Kmiec
      Biochemical and Biophysical Research Communications 2003 310 2
    • Gene Therapy for Neurological Disorders
      Deborah Young
      2016 1382
    • Genetics of Movement Disorders
      David C. Rubinsztein
      2003
    • Genomic Approaches for Cross-Species Extrapolation in Toxicology
      Nancy Denslow, John Colbourne, David Dix, Jonathan Freedman, Caren Helbing, Sean Kennedy, Phillip Williams
      2006
    • Mutations in the pqe-1 Gene Enhance Transgene Expression in Caenorhabditis elegans
      Koji Yamada, Jun-ichi Tsuchiya, Yuichi Iino
      G3: Genes|Genomes|Genetics 2012 2 7
    • Protein Quality Control in Neurodegenerative Diseases
      Eric Guisbert, Richard I. Morimoto
      2013
    • Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration
      Saba N. Baskoylu, Jill Yersak, Patrick O’Hern, Sarah Grosser, Jonah Simon, Sarah Kim, Kelsey Schuch, Maria Dimitriadi, Katherine S. Yanagi, Jeremy Lins, Anne C. Hart, Gregory S. Barsh
      PLOS Genetics 2018 14 10
    • Drosophilaas a model to study the role of glia in neurodegeneration
      Yuan-Ming Lee, Y. Henry Sun
      Journal of Neurogenetics 2015 29 2-3
    • Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Caenorhabditis elegans Model of Tauopathy
      Andrea Gamir-Morralla, Sandra Sacristán, Miguel Medina, Teresa Iglesias
      Journal of Alzheimer's Disease Reports 2019 3 1
    • In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
      Roel Van Assche, Charline Borghgraef, Jonathan Vaneyck, Mireille Dumoulin, Liliane Schoofs, Liesbet Temmerman
      Journal of Negative Results in BioMedicine 2017 16 1
    • Models and mechanisms of repeat expansion disorders: a worm’s eye view
      Paige Rudich, Todd Lamitina
      Journal of Genetics 2018 97 3
    • Neuronal Death by Accident or by Design
      S. Humbert, F. Saudou
      2001
    • Protein Misfolding, Aggregation, and Conformational Diseases
      Julide Bilen, Nancy M. Bonini
      2006 4
    • A link between chromatin condensation mechanisms and Huntington's disease: connecting the dots
      Sonali Lokhande, Biranchi N. Patra, Animesh Ray
      Molecular BioSystems 2016 12 12
    • Ageing: Lessons from C. elegans
      Silvestre Alavez
      2017
    • Aging of Organisms
      Anders Olsen, James N. Sampayo, Gordon J. Lithgow
      2003
    • Animal Models of Movement Disorders
      SUVI VARTIAINEN, GARRY WONG
      2005
    • Animal Models of Movement Disorders
      GUY A. CALDWELL, SONGSONG CAO, IYARE IZEVBAYE, KIM A. CALDWELL
      2005
    • Behavioral analysis of the huntingtin-associated protein 1 ortholog trak-1 inCaenorhabditis elegans
      Fran Norflus, Jingnan Bu, Evon Guyton, Claire-Anne Gutekunst
      Journal of Neuroscience Research 2016 94 9
    • Cellular Transplantation
      Carole Escartin, Philippe Hantraye, Nicole Déglon
      2007
    • Comparative Analysis of Mutant Huntingtin Binding Partners in Yeast Species
      Yanding Zhao, Ashley A. Zurawel, Nicole P. Jenkins, Martin L. Duennwald, Chao Cheng, Arminja N. Kettenbach, Surachai Supattapone
      Scientific Reports 2018 8 1
    • Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders
      Terry Jo Bichell, Michael Uhouse, Emma Bradley, Aaron B. Bowman
      2015
    • Genetic Instabilities and Neurological Diseases
      JOHN S. BETT, GILLIAN P. BATES, EMMA HOCKLY
      2006
    • Genetics of Movement Disorders
      J. William Langston, Lawrence I. Golbe, Seung-Jae Lee
      2003
    • Handbook of Contemporary Neuropharmacology
      Richard Nass, Charles D. Nichols
      2007
    • Huntington’s Disease
      Anjalika Chongtham, Brett Barbaro, Tomas Filip, Adeela Syed, Weijian Huang, Marianne R. Smith, J. Lawrence Marsh
      2018 1780
    • Huntington’s Disease
      Emma Yhnell, Andreas Heuer
      2018 1780
    • Modern approaches for modelling dystonia and Huntington's disease in vitro and in vivo
      Olga A. Zhunina, Nikita G. Yabbarov, Alexander N. Orekhov, Alexey V. Deykin
      International Journal of Experimental Pathology 2019 100 2
    • Movement Disorders
      Robert P. Mason, Carlo Breda, Gurdeep S. Kooner, Giovanna R. Mallucci, Charalambos P. Kyriacou, Flaviano Giorgini
      2015
    • Neurochemical Mechanisms in Disease
      Imad Ghorayeb, Guylène Page, Afsaneh Gaillard, Mohamed Jaber
      2011 1
    • Neurodegeneration
      Salman Haider, Edward Wild, Sarah J. Tabrizi
      2017
    • Neurodegeneration and Prion Disease
      Ramanujan S. Hegde, Neena S. Rane
      2005
    • Neurodegenerative Diseases
      Michael Y. Sherman, Alfred L. Goldberg
      2005
    • Neurogenetics
      Lynn Raymond, Blair Leavitt
      2005
    • Neurogenetics of Psychiatric Disorders
      David E. Krantz, George R. Jackson
      2007
    • Organ-on-a-chip
      Sudip Mondal, Adela Ben-Yakar
      2020
    • Protein Misfolding Diseases
      Elise A. Kikis, Anat Ben-Zvi, Richard I. Morimoto
      2010
    • Protein Misfolding, Aggregation, and Conformational Diseases
      Seung-Jae Lee, Yoon Suk Kim
      2007 6
    • Quality Control in Huntington’s Disease: a Therapeutic Target
      Sachchida Nand Rai, Brijesh Kumar Singh, Aaina Singh Rathore, Walia Zahra, Chetan Keswani, Hareram Birla, Saumitra Sen Singh, Hagera Dilnashin, Surya Pratap Singh
      Neurotoxicity Research 2019 36 3
    • Sourcebook of Models for Biomedical Research
      Richard Nass, Lihsia Chen
      2008
    • Un Nématode Prix Nobel : Caenorhabditis elegans
      J. Savel, F. Clostre
      Annales Pharmaceutiques Françaises 2006 64 5

    Article usage

    Article usage: January 1999 to December 2019

    AbstractFullPdf
    Jan 1999228196220
    Feb 1999154534
    Mar 1999165364
    Apr 1999153050
    May 1999113115
    Jun 1999112423
    Jul 199951823
    Aug 199951916
    Sep 199913230
    Oct 199962927
    Nov 199974439
    Dec 1999111622
    Total 1999331537563
    Jan 200042544
    Feb 2000243718
    Mar 2000102421
    Apr 200083438
    May 200082427
    Jun 200051725
    Jul 200071722
    Aug 200051715
    Sep 20004911
    Oct 200061815
    Nov 200022716
    Dec 200062014
    Total 200089269266
    Jan 200183124
    Feb 200192841
    Mar 200161922
    Apr 200153125
    May 200191213
    Jun 2001288
    Jul 200112016
    Aug 200112915
    Sep 200122419
    Oct 200142119
    Nov 200141614
    Dec 200112212
    Total 200152261228
    Jan 200221718
    Feb 200231511
    Mar 200232221
    Apr 200241721
    May 200281010
    Jun 2002321616
    Jul 200251518
    Aug 20021810
    Sep 20021117
    Oct 200231717
    Nov 200231011
    Dec 200241218
    Total 200269170178
    Jan 20035159
    Feb 200351818
    Mar 2003131911
    Apr 200331516
    May 200332519
    Jun 200351212
    Jul 200311118
    Aug 200316135
    Sep 2003102024
    Oct 2003192223
    Nov 2003132916
    Dec 2003111211
    Total 2003114211172
    Jan 2004142414
    Feb 2004183936
    Mar 2004192131
    Apr 2004322733
    May 2004103332
    Jun 2004232921
    Jul 200416298
    Aug 2004192414
    Sep 200413339
    Oct 200413198
    Nov 2004123916
    Dec 2004143914
    Total 2004203356236
    Jan 200542714
    Feb 200561515
    Mar 200531612
    Apr 200502015
    May 200522314
    Jun 200571410
    Jul 200532016
    Aug 200551418
    Sep 20057107
    Oct 20059248
    Nov 200543231
    Dec 20056189
    Total 200556233169
    Jan 20067239
    Feb 200693011
    Mar 200674119
    Apr 200653116
    May 2006102011
    Jun 20066315
    Jul 200672010
    Aug 20067239
    Sep 200611174
    Oct 2006152211
    Nov 2006142614
    Dec 2006223111
    Total 2006120315130
    Jan 200782215
    Feb 200752911
    Mar 200752212
    Apr 2007131915
    May 2007171719
    Jun 200751910
    Jul 20076138
    Aug 200714106
    Sep 2007188
    Oct 200711169
    Nov 200721910
    Dec 2007298
    Total 200789203131
    Jan 200851110
    Feb 2008398
    Mar 2008789
    Apr 2008151323
    May 2008121916
    Jun 200891519
    Jul 200814411
    Aug 20081657
    Sep 200822811
    Oct 200831915
    Nov 200817511
    Dec 20081639
    Total 2008167109149
    Jan 20091826
    Feb 200919610
    Mar 20091265
    Apr 2009211817
    May 2009171320
    Jun 200910118
    Jul 200941916
    Aug 20097117
    Sep 2009111812
    Oct 200910159
    Nov 2009144612
    Dec 200916157
    Total 2009159180129
    Jan 2010797
    Feb 201061710
    Mar 201014167
    Apr 201012167
    May 201014168
    Jun 20106124
    Jul 20105335
    Aug 20104176
    Sep 20105206
    Oct 2010668
    Nov 20105174
    Dec 2010852
    Total 20109218474
    Jan 20117158
    Feb 201113236
    Mar 201112410
    Apr 201110912
    May 2011132231
    Jun 201171017
    Jul 201181113
    Aug 20114710
    Sep 20111147
    Oct 2011131029
    Nov 2011151011
    Dec 2011744
    Total 2011120129158
    Jan 2012141112
    Feb 20121479
    Mar 2012241014
    Apr 2012141814
    May 2012132414
    Jun 2012121614
    Jul 20126179
    Aug 201210413
    Sep 20126710
    Oct 201214811
    Nov 20121261
    Dec 2012191630
    Total 2012158144151
    Jan 2013191619
    Feb 2013121714
    Mar 20138927
    Apr 20131987
    May 2013161310
    Jun 20131097
    Jul 2013111210
    Aug 201310711
    Sep 201313610
    Oct 2013211710
    Nov 201311912
    Dec 201318179
    Total 2013168140146
    Jan 20141096
    Feb 20147207
    Mar 201410528
    Apr 2014161113
    May 201415108
    Jun 2014161415
    Jul 2014111510
    Aug 201422223
    Sep 201412176
    Oct 2014271611
    Nov 2014161218
    Dec 201427198
    Total 2014189217113
    Jan 201532189
    Feb 20151234
    Mar 2015251415
    Apr 201522913
    May 201571113
    Jun 20151058
    Jul 2015599
    Aug 20155812
    Sep 201517169
    Oct 201571129
    Nov 2015121321
    Dec 201527510
    Total 2015181122152
    Jan 2016717
    Feb 20161028
    Mar 2016251117
    Apr 2016231120
    May 201613812
    Jun 20161295
    Jul 20161274
    Aug 2016841
    Sep 20162227
    Oct 20161593
    Nov 201615210
    Dec 2016211013
    Total 201618376107
    Jan 20171455
    Feb 201714121
    Mar 201725118
    Apr 20172053
    May 2017141118
    Jun 20172356
    Jul 201724810
    Aug 20171978
    Sep 20172068
    Oct 20171734
    Nov 2017576
    Dec 20171275
    Total 20172078782
    Jan 20181063
    Feb 2018132013
    Mar 201818227
    Apr 201819157
    May 201818147
    Jun 201813133
    Jul 201813157
    Aug 201818198
    Sep 201818207
    Oct 20185226
    Nov 20183257
    Dec 20189218
    Total 201815721283
    Jan 20193115
    Feb 20192115
    Mar 201962412
    Apr 201973210
    May 20195227
    Jun 20193152
    Jul 201942012
    Aug 20194712
    Sep 201921611
    Oct 20195186
    Nov 20195307
    Dec 2019093
    Total 20194621592
    Total295043703509
    PreviousNext
    Back to top
    Article Alerts
    Email Article

    Thank you for your interest in spreading the word on PNAS.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron
    (Your Name) has sent you a message from PNAS
    (Your Name) thought you would like to see the PNAS web site.
    Citation Tools
    Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron
    Peter W. Faber, Janet R. Alter, Marcy E. MacDonald, Anne C. Hart
    Proceedings of the National Academy of Sciences Jan 1999, 96 (1) 179-184; DOI: 10.1073/pnas.96.1.179

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Request Permissions
    Share
    Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron
    Peter W. Faber, Janet R. Alter, Marcy E. MacDonald, Anne C. Hart
    Proceedings of the National Academy of Sciences Jan 1999, 96 (1) 179-184; DOI: 10.1073/pnas.96.1.179
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Mendeley logo Mendeley
    Proceedings of the National Academy of Sciences: 116 (50)
    Current Issue

    Submit

    Sign up for Article Alerts

    Jump to section

    • Article
      • Abstract
      • MATERIALS AND METHODS
      • RESULTS
      • DISCUSSION
      • Acknowledgments
      • Footnotes
      • ABBREVIATIONS
      • References
    • Figures & SI
    • Info & Metrics
    • PDF

    You May Also be Interested in

    News Feature: Getting the world’s fastest cat to breed with speed
    Cheetahs once rarely reproduced in captivity. Today, cubs are born every year in zoos. Breeding programs have turned their luck around—but they aren’t done yet.
    Image credit: Mehgan Murphy/Smithsonian Conservation Biology Institute.
    Adaptations in heart structure and function likely enabled endurance and survival in preindustrial humans. Image courtesy of Pixabay/Skeeze.
    Human heart evolved for endurance
    Adaptations in heart structure and function likely enabled endurance and survival in preindustrial humans.
    Image courtesy of Pixabay/Skeeze.
    Viscoelastic carrier fluids enhance retention of fire retardants on wildfire-prone vegetation. Image courtesy of Jesse D. Acosta.
    Viscoelastic fluids and wildfire prevention
    Viscoelastic carrier fluids enhance retention of fire retardants on wildfire-prone vegetation.
    Image courtesy of Jesse D. Acosta.
    Water requirements may make desert bird declines more likely in a warming climate. Image courtesy of Sean Peterson (photographer).
    Climate change and desert bird collapse
    Water requirements may make desert bird declines more likely in a warming climate.
    Image courtesy of Sean Peterson (photographer).
    QnAs with NAS member and plant biologist Sheng Yang He. Image courtesy of Sheng Yang He.
    Featured QnAs
    QnAs with NAS member and plant biologist Sheng Yang He
    Image courtesy of Sheng Yang He.

    Similar Articles

    Site Logo
    Powered by HighWire
    • Submit Manuscript
    • Twitter
    • Facebook
    • RSS Feeds
    • Email Alerts

    Articles

    • Current Issue
    • Latest Articles
    • Archive

    PNAS Portals

    • Classics
    • Front Matter
    • Teaching Resources
    • Anthropology
    • Chemistry
    • Physics
    • Sustainability Science

    Information

    • Authors
    • Editorial Board
    • Reviewers
    • Press
    • Site Map
    • PNAS Updates

    Feedback    Privacy/Legal

    Copyright © 2019 National Academy of Sciences. Online ISSN 1091-6490